Applied Clinical Trials-09-01-2020

A compilation of recent notable news developments that pertain to the clinical trials industry.

A look at how real world data and real world evidence are shaping more decentralized trial designs for potential COVID-19 treatments.

Study offers clues for installing rapid R&D tactics post-pandemic.

Though the global pandemic that has affected millions, the industry has shown resilience and demonstrated a shared commitment to improving patient care.

As biopharma companies and research institutes advance the development of promising vaccines against COVID-19, policy makers and health officials have intensified deliberations on strategies for ensuring fair and equitable distribution of anticipated preventives.

FDA to resume “prioritized domestic inspections” for certain regulated products put on hold by COVID-19.

Despite the rush for an effective COVID-19 therapy, biotech industry leaders insist rigorous research and complete data will be the standard preceding approvals.

Rasmus Hogreffe, former Head of Virtual Trials at LEO Innovation Lab, and current VP of Decentralized Trial Innovation at Medable, and Morten Kirkegaard, Head of Clinical Operations and Co-founder at REDO-neurosystems, discuss their experiences with decentralized trials.

Industry experts share their thoughts on the evolution of the functional service provider model, as demand for flexible resourcing grows.

A look into the future based off what we've learned about trials during the pandemic.

Stakes are high for emerging biopharmaceutical companies to get their relationships with CRO partners right from the outset.

Click the title above for a link to open the Applied Clinical Trials September 2020 issue in an interactive PDF format.

The European Commission has concluded exploratory talks, with Moderna, over the purchase of a fifth potential vaccine against COVID-19.

A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.

Europe is aiming to improve its medium-term planning for citizens' health with an agenda that aims to "enable and leverage research and innovation in regulatory science."

Competency-based and other creative approaches are needed to address the battle for talent in the clinical research workforce.

A compilation of ACT's most popular content from the previous month plus a look at upcoming webcasts.